Bausch + Lomb Corp (BLCO) - Total Liabilities
Based on the latest financial reports, Bausch + Lomb Corp (BLCO) has total liabilities worth CA$7.33 Billion CAD (≈ $5.30 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Bausch + Lomb Corp - Total Liabilities Trend (2019–2024)
This chart illustrates how Bausch + Lomb Corp's total liabilities have evolved over time, based on quarterly financial data. See BLCO net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Bausch + Lomb Corp Competitors by Total Liabilities
The table below lists competitors of Bausch + Lomb Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Amentum Holdings Inc.
NYSE:AMTM
|
USA | $6.54 Billion |
|
Gecina SA
PA:GFC
|
France | €7.44 Billion |
|
Installed Building Products Inc
NYSE:IBP
|
USA | $1.56 Billion |
|
Leo Group Co Ltd
SHE:002131
|
China | CN¥8.03 Billion |
|
AMMB Holdings Bhd
KLSE:1015
|
Malaysia | RM185.74 Billion |
|
West Fraser Timber Co Ltd
TO:WFG
|
Canada | CA$2.03 Billion |
|
Janus Living, Inc.
NYSE:JAN
|
USA | $977.86 Million |
|
Caitong Securities Co Ltd
SHG:601108
|
China | CN¥138.80 Billion |
Liability Composition Analysis (2019–2024)
This chart breaks down Bausch + Lomb Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BLCO market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.51 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.53 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bausch + Lomb Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bausch + Lomb Corp (2019–2024)
The table below shows the annual total liabilities of Bausch + Lomb Corp from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CA$6.92 Billion ≈ $5.01 Billion |
+6.18% |
| 2023-12-31 | CA$6.52 Billion ≈ $4.72 Billion |
+61.32% |
| 2022-12-31 | CA$4.04 Billion ≈ $2.92 Billion |
+184.52% |
| 2021-12-31 | CA$1.42 Billion ≈ $1.03 Billion |
+11.19% |
| 2020-12-31 | CA$1.28 Billion ≈ $924.49 Million |
-11.00% |
| 2019-12-31 | CA$1.44 Billion ≈ $1.04 Billion |
-- |
About Bausch + Lomb Corp
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily d… Read more